Drug-Target Continuous Binding Affinity Prediction using Multiple Sources of Information

2021 ◽  
pp. 115810
Author(s):  
Betsabeh Tanoori ◽  
Mansoor Zolghadri Jahromi ◽  
Eghbal G. Mansoori
Keyword(s):  
Binding Affinity ◽  
Drug Target ◽  
Sources Of Information ◽  
Multiple Sources ◽  
Binding Affinity Prediction ◽  
Affinity Prediction

scholarly journals MGraphDTA: deep multiscale graph neural network for explainable drug–target binding affinity prediction

2022 ◽  
Author(s):  
Ziduo Yang ◽  
Weihe Zhong ◽  
Lu Zhao ◽  
Calvin Yu-Chian Chen
Keyword(s):  
Neural Network ◽  
Binding Affinity ◽  
Drug Target ◽  
Global Structure ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Target Binding

MGraphDTA is designed to capture the local and global structure of a compound simultaneously for drug–target affinity prediction and can provide explanations that are consistent with pharmacologists.

scholarly journals Prediction of drug–target binding affinity using similarity-based convolutional neural network

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jooyong Shim ◽  
Zhen-Yu Hong ◽  
Insuk Sohn ◽  
Changha Hwang
Keyword(s):  
Neural Network ◽  
Convolutional Neural Network ◽  
Binding Affinity ◽  
Drug Target ◽  
Binary Classification ◽  
Binding Affinities ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Target Binding ◽  
Public Datasets

AbstractIdentifying novel drug–target interactions (DTIs) plays an important role in drug discovery. Most of the computational methods developed for predicting DTIs use binary classification, whose goal is to determine whether or not a drug–target (DT) pair interacts. However, it is more meaningful but also more challenging to predict the binding affinity that describes the strength of the interaction between a DT pair. If the binding affinity is not sufficiently large, such drug may not be useful. Therefore, the methods for predicting DT binding affinities are very valuable. The increase in novel public affinity data available in the DT-related databases enables advanced deep learning techniques to be used to predict binding affinities. In this paper, we propose a similarity-based model that applies 2-dimensional (2D) convolutional neural network (CNN) to the outer products between column vectors of two similarity matrices for the drugs and targets to predict DT binding affinities. To our best knowledge, this is the first application of 2D CNN in similarity-based DT binding affinity prediction. The validation results on multiple public datasets show that the proposed model is an effective approach for DT binding affinity prediction and can be quite helpful in drug development process.

scholarly journals DeepDTA: deep drug–target binding affinity prediction

2018 ◽  
Vol 34 (17) ◽  
pp. i821-i829 ◽  
Author(s):  
Hakime Öztürk ◽  
Arzucan Özgür ◽  
Elif Ozkirimli
Keyword(s):  
Binding Affinity ◽  
Drug Target ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Target Binding

GRAM: A True Null Model for Relative Binding Affinity Predictions

2019 ◽  
Author(s):  
Guanglei Cui ◽  
Alan P. Graves ◽  
Eric S. Manas
Keyword(s):  
Binding Affinity ◽  
Performance Metrics ◽  
Null Model ◽  
Performance Measure ◽  
Interval Estimate ◽  
Empirical Observation ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Relative Binding Affinity ◽  
Relative Binding

Relative binding affinity prediction is a critical component in computer aided drug design. Significant amount of effort has been dedicated to developing rapid and reliable in silico methods. However, robust assessment of their performance is still a complicated issue, as it requires a performance measure applicable in the prospective setting and more importantly a true null model that defines the expected performance of random in an objective manner. Although many performance metrics, such as correlation coefficient (r2), mean unsigned error (MUE), and room mean square error (RMSE), are frequently used in the literature, a true and non-trivial null model has yet been identified. To address this problem, here we introduce an interval estimate as an additional measure, namely prediction interval (PI), which can be estimated from the error distribution of the predictions. The benefits of using the interval estimate are 1) it provides the uncertainty range in the predicted activities, which is important in prospective applications; 2) a true null model with well-defined PI can be established. We provide one such example termed Gaussian Random Affinity Model (GRAM), which is based on the empirical observation that the affinity change in a typical lead optimization effort has the tendency to distribute normally N (0, s). Having an analytically defined PI that only depends on the variation in the activities, GRAM should in principle allow us to compare the performance of relative binding affinity prediction methods in a standard way, ultimately critical to measuring the progress made in algorithm development.<br>

Improving the Accuracy of Protein-Ligand Binding Affinity Prediction by Deep Learning Models: Benchmark and Model

2019 ◽  
Author(s):  
Mohammad Rezaei ◽  
Yanjun Li ◽  
Xiaolin Li ◽  
Chenglong Li
Keyword(s):  
Deep Learning ◽  
Drug Design ◽  
Binding Affinity ◽  
Benchmark Dataset ◽  
Rational Drug Design ◽  
Learning Models ◽  
Structure Based Drug Design ◽  
Binding Affinity Prediction ◽  
Affinity Prediction ◽  
Rational Drug

<b>Introduction:</b> The ability to discriminate among ligands binding to the same protein target in terms of their relative binding affinity lies at the heart of structure-based drug design. Any improvement in the accuracy and reliability of binding affinity prediction methods decreases the discrepancy between experimental and computational results.<br><b>Objectives:</b> The primary objectives were to find the most relevant features affecting binding affinity prediction, least use of manual feature engineering, and improving the reliability of binding affinity prediction using efficient deep learning models by tuning the model hyperparameters.<br><b>Methods:</b> The binding site of target proteins was represented as a grid box around their bound ligand. Both binary and distance-dependent occupancies were examined for how an atom affects its neighbor voxels in this grid. A combination of different features including ANOLEA, ligand elements, and Arpeggio atom types were used to represent the input. An efficient convolutional neural network (CNN) architecture, DeepAtom, was developed, trained and tested on the PDBbind v2016 dataset. Additionally an extended benchmark dataset was compiled to train and evaluate the models.<br><b>Results: </b>The best DeepAtom model showed an improved accuracy in the binding affinity prediction on PDBbind core subset (Pearson’s R=0.83) and is better than the recent state-of-the-art models in this field. In addition when the DeepAtom model was trained on our proposed benchmark dataset, it yields higher correlation compared to the baseline which confirms the value of our model.<br><b>Conclusions:</b> The promising results for the predicted binding affinities is expected to pave the way for embedding deep learning models in virtual screening and rational drug design fields.

Sign in / Sign up

Export Citation Format

Share Document